Shuhei Komatsu

17PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 31, 2026
Robotic Versus Laparoscopic Gastrectomy for Advanced Gastric Cancer: Prognostic Implications of Surgical Recovery and Oncologic Control in a Propensity Score-Matched Study.

|Apr 06, 2026
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study.

Takuma Ohashi, Takeshi Kubota, Hayato Fukui

|Jul 27, 2025
Low levels of tumor suppressor miR-3619 in plasma contribute to malignant outcomes and a target for nucleic acid therapy in esophageal cancer.

Hiroshi Arakawa, Shuhei Komatsu, Takuma Kishimoto

|Sep 20, 2024
Extracellular glypican-1 affects tumor progression and prognosis in esophageal cancer.

Rie Shibata, Hirotaka Konishi, Tomohiro Arita

|Dec 26, 2023
Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.

Hajime Kamiya, Shuhei Komatsu, Yusuke Takashima

|May 16, 2023
Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.

Yusuke Takashima, Shuhei Komatsu, Takuma Ohashi

Pageof 3

Frequent Collaborators

8 joint publications

Hirotaka Konishi

8 joint publications

Atsushi Shiozaki

3 joint publications

Tomohiro Arita

3 joint publications

Eigo Otsuji